The purpose of this study is to determine the appropriate dose of the investigational drugs, Tomudex and 5-Iodo-2'-Deoxyuridine (IdUrd) when given together on a once every-three-week schedule to pts with advanced solid tumor cancers. The side effects experienced with the drugs and how the body uses and removes IdUrd to be studied, also.
Showing the most recent 10 out of 1267 publications